Weaving LS , Ellaway CJ , Gécz J , Christodoulou J .

Aber, Methyl-CpG-binding protein 2 is localized in the postsynaptic compartment: an immunochemical study of subcellular fractions. 2003, Pubmed

Aber, Methyl-CpG-binding protein 2 is localized in the postsynaptic compartment: an immunochemical study of subcellular fractions. 2003, Pubmed
Adler, The X-linked methylated DNA binding protein, Mecp2, is subject to X inactivation in the mouse. 1995, Pubmed
Akbarian, Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. 2001, Pubmed
Amir, Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations. 2000, Pubmed
Amir, Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. 2000, Pubmed
Anvret, Rett syndrome: random X chromosome inactivation. 1994, Pubmed
Ariani, Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: Report of one case of MECP2 deletion and one case of MECP2 duplication. 2004, Pubmed
Balmer, MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. 2002, Pubmed
Beyer, Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. 2002, Pubmed
Braunschweig, X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain. 2004, Pubmed
Brunner, Genomic structure and comparative analysis of nine Fugu genes: conservation of synteny with human chromosome Xp22.2-p22.1. 1999, Pubmed
Budden, Rett syndrome: habilitation and management reviewed. 1997, Pubmed
Budden, Management of Rett syndrome: a ten year experience. 1995, Pubmed
Buschdorf, A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome. 2004, Pubmed
Camus, X chromosome inactivation in 30 girls with Rett syndrome: analysis using the probe. 1996, Pubmed
Chen, Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. 2001, Pubmed
Chen, Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. 2003, Pubmed
Christodoulou, RettBASE: The IRSA MECP2 variation database-a new mutation database in evolution. 2003, Pubmed
Colantuoni, Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. 2001, Pubmed
Colvin, Refining the phenotype of common mutations in Rett syndrome. 2004, Pubmed
Coy, A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3"-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. 1999, Pubmed
D'Esposito, Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. 1996, Pubmed
Dotti, A Rett syndrome MECP2 mutation that causes mental retardation in men. 2002, Pubmed
Egger, Magnesium for hyperventilation in Rett's syndrome. 1992, Pubmed
Ellaway, A case of multiple congenital anomalies in association with Rett syndrome confirmed by MECP2 mutation screening. 2001, Pubmed
Ellaway, Rett syndrome: randomized controlled trial of L-carnitine. 1999, Pubmed
Ellaway, Prolonged QT interval in Rett syndrome. 1999, Pubmed
Ellaway, Medium-term open label trial of L-carnitine in Rett syndrome. 2001, Pubmed
Erlandson, Multiplex ligation-dependent probe amplification (MLPA) detects large deletions in the MECP2 gene of Swedish Rett syndrome patients. 2003, Pubmed
Giardina, Mutational analysis of Peroxiredoxin IV: exclusion of a positional candidate for multinodular goitre. 2002, Pubmed
Girard, Parental origin of de novo MECP2 mutations in Rett syndrome. 2001, Pubmed
Glaze, Rett syndrome: characterization of seizures versus non-seizures. 1998, Pubmed
Guy, A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. 2001, Pubmed
Hagberg, Rett syndrome: epidemiology and geographical variability. 1997, Pubmed
Hagberg, An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. 2002, Pubmed
Hagberg, Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. 1986, Pubmed
Hagberg, A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. 1983, Pubmed
Hagberg, Rett syndrome: clinical peculiarities and biological mysteries. 1995, Pubmed
Hanks, Motor disabilities in the Rett syndrome and physical therapy strategies. 1990, Pubmed
Hoffbuhr, MeCP2 mutations in children with and without the phenotype of Rett syndrome. 2001, Pubmed
Hoffbuhr, Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. 2002, Pubmed
Huopaniemi, Characterization of two unusual RS1 gene deletions segregating in Danish retinoschisis families. 2000, Pubmed
Huppke, Influence of mutation type and location on phenotype in 123 patients with Rett syndrome. 2002, Pubmed
Jones, Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. 1998, Pubmed , Xenbase
Jung, The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. 2003, Pubmed
Kalscheuer, Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation. 2003, Pubmed
Kerr, Review article: breaking new ground with Rett syndrome. 2003, Pubmed
Kerr, Guidelines for reporting clinical features in cases with MECP2 mutations. 2001, Pubmed
Klauck, A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. 2002, Pubmed
Kleefstra, De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia. 2002, Pubmed
Kleefstra, MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics. 2004, Pubmed
Klose, Molecular biology. MeCP2 repression goes nonglobal. 2003, Pubmed , Xenbase
Kokura, The Ski protein family is required for MeCP2-mediated transcriptional repression. 2001, Pubmed
Krepischi, X chromosome-inactivation patterns in patients with Rett syndrome. 1998, Pubmed
Kriaucionis, The major form of MeCP2 has a novel N-terminus generated by alternative splicing. 2004, Pubmed
Laccone, Mutation spectrum in patients with Rett syndrome in the German population: Evidence of hot spot regions. 2001, Pubmed
Laccone, Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome. 2004, Pubmed
Leonard, The prevalence and incidence of Rett syndrome in Australia. 1997, Pubmed
Leonard, Trisomy 21 and Rett syndrome: a double burden. 2004, Pubmed
Martinowich, DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. 2003, Pubmed
McArthur, Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. 1998, Pubmed
Meloni, A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. 2000, Pubmed
Migeon, Studies of X inactivation and isodisomy in twins provide further evidence that the X chromosome is not involved in Rett syndrome. 1995, Pubmed
Miltenberger-Miltenyi, Mutations and polymorphisms in the human methyl CpG-binding protein MECP2. 2003, Pubmed
Montini, Identification and characterization of a novel serine-threonine kinase gene from the Xp22 region. 1998, Pubmed
Moog, Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). 2003, Pubmed
Nan, Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. 1998, Pubmed
Orrico, MECP2 mutation in male patients with non-specific X-linked mental retardation. 2000, Pubmed
Plioplys, L-carnitine as a treatment for Rett syndrome. 1993, Pubmed
Rett, [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. 1966, Pubmed
Schanen, Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome. 2004, Pubmed
Schollen, Gross rearrangements in the MECP2 gene in three patients with Rett syndrome: implications for routine diagnosis of Rett syndrome. 2003, Pubmed
Schwartzman, Rett syndrome in a boy with a 47,XXY karyotype confirmed by a rare mutation in the MECP2 gene. 2001, Pubmed
Sekul, Electrocardiographic findings in Rett syndrome: an explanation for sudden death? 1994, Pubmed
Shahbazian, Balanced X chromosome inactivation patterns in the Rett syndrome brain. 2002, Pubmed
Shahbazian, Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. 2002, Pubmed
Stancheva, A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. 2003, Pubmed , Xenbase
Strømme, Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. 2002, Pubmed
Thomas, High male:female ratio of germ-line mutations: an alternative explanation for postulated gestational lethality in males in X-linked dominant disorders. 1996, Pubmed
Topçu, Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. 2002, Pubmed
Trappe, MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. 2001, Pubmed
Tudor, Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. 2002, Pubmed
Wan, Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. 1999, Pubmed
Watson, Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. 2001, Pubmed
Weaving, Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. 2003, Pubmed
Webb, Neither uniparental disomy nor skewed X-inactivation explains Rett syndrome. 1993, Pubmed
Webb, A comparative study of X-inactivation in Rett syndrome probands and control subjects. 1996, Pubmed
Yntema, Low frequency of MECP2 mutations in mentally retarded males. 2002, Pubmed
Young, X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome. 2004, Pubmed
Yu, Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2. 2000, Pubmed
Zoghbi, Patterns of X chromosome inactivation in the Rett syndrome. 1990, Pubmed